198 related articles for article (PubMed ID: 35806169)
21. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
22. γ-Secretase Inhibitor, DAPT Inhibits Self-renewal and Stemness Maintenance of Ovarian Cancer Stem-like Cells In Vitro.
Jiang LY; Zhang XL; Du P; Zheng JH
Chin J Cancer Res; 2011 Jun; 23(2):140-6. PubMed ID: 23482909
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract][Full Text] [Related]
24. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
Ling K; Jiang L; Liang S; Kwong J; Yang L; Li Y; PingYin ; Deng Q; Liang Z
J Ovarian Res; 2018 May; 11(1):36. PubMed ID: 29716628
[TBL] [Abstract][Full Text] [Related]
25. SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells.
Yue Y; Xia L; Xu S; Wang C; Wang X; Lu W; Xie X
J Gynecol Oncol; 2020 Jul; 31(4):e46. PubMed ID: 32026660
[TBL] [Abstract][Full Text] [Related]
26. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
[TBL] [Abstract][Full Text] [Related]
27. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis.
Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
Li M; Chai HF; Peng F; Meng YT; Zhang LZ; Zhang L; Zou H; Liang QL; Li MM; Mao KG; Sun DX; Tong MY; Deng ZQ; Hou ZJ; Zhao Y; Li J; Wang XC; Lv SS; Zhang QQ; Yu X; Lam EW; Liu Q; Cui XN; Xu J
Cell Death Dis; 2018 Nov; 9(11):1120. PubMed ID: 30389909
[TBL] [Abstract][Full Text] [Related]
29. Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer.
Datta J; Willingham N; Manouchehri JM; Schnell P; Sheth M; David JJ; Kassem M; Wilson TA; Radomska HS; Coss CC; Bennett CE; Ganju RK; Sardesai SD; Lustberg M; Ramaswamy B; Stover DG; Cherian MA
Front Oncol; 2022; 12():857590. PubMed ID: 35574319
[TBL] [Abstract][Full Text] [Related]
30. Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2.
Peng Q; Qin J; Zhang Y; Cheng X; Wang X; Lu W; Xie X; Zhang S
J Exp Clin Cancer Res; 2017 Nov; 36(1):171. PubMed ID: 29187221
[TBL] [Abstract][Full Text] [Related]
31. Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.
Schüler-Toprak S; Moehle C; Skrzypczak M; Ortmann O; Treeck O
BMC Cancer; 2017 May; 17(1):319. PubMed ID: 28482871
[TBL] [Abstract][Full Text] [Related]
32. Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.
Wilczyński JR; Wilczyński M; Paradowska E
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269636
[TBL] [Abstract][Full Text] [Related]
33. Synergistic ultrasonic biophysical effect-responsive nanoparticles for enhanced gene delivery to ovarian cancer stem cells.
Liufu C; Li Y; Lin Y; Yu J; Du M; Chen Y; Yang Y; Gong X; Chen Z
Drug Deliv; 2020 Dec; 27(1):1018-1033. PubMed ID: 32627597
[TBL] [Abstract][Full Text] [Related]
34. Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis.
Li Y; Hu Y; Yang L; Liu J; Cui C; Yang M; Zou D; Zhou L; Zhou Q; Ge W; Lang T
Biomed Pharmacother; 2023 Apr; 160():114350. PubMed ID: 36804120
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound microbubbles mediated miR-let-7b delivery into CD133
Yang C; Li B; Yu J; Yang F; Cai K; Chen Z
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126854
[TBL] [Abstract][Full Text] [Related]
36. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
37. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
38. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
39. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
[No Abstract] [Full Text] [Related]
40. [Effects of estrogen receptor beta on proliferation of ovarian clear cell adenocarcinoma ES-2 in vitro and in vivo].
Zhu J; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):588-91. PubMed ID: 17181966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
